| 来源类型 | Working Paper
|
| 规范类型 | 报告
|
| DOI | 10.3386/w22523
|
| 来源ID | Working Paper 22523
|
| Immunization and Moral Hazard: The HPV Vaccine and Uptake of Cancer Screening |
| Ali Moghtaderi; Avi Dor
|
| 发表日期 | 2016-08-22
|
| 出版年 | 2016
|
| 语种 | 英语
|
| 摘要 | Immunization can cause moral hazard by reducing the cost of risky behaviors. In this study, we examine the effect of HPV vaccination for cervical cancer on participation in the Pap test, which is a diagnostic screening test to detect potentially precancerous and cancerous process. It is strongly recommended for women between 21-65 years old even after taking the HPV vaccine. A reduction in willingness to have a Pap test as a result of HPV vaccination would signal the need for public health intervention. The HPV vaccination is recommended for women age eleven to twelve for regular vaccination or for women up to age 26 not vaccinated previously. We present evidence that probability of vaccination changes around this threshold. We identify the effect of vaccination using a fuzzy regression discontinuity design, centered on the recommended vaccination threshold age. The results show no evidence of ex ante moral hazard in the short-run. Sensitivity analyses using alternative specifications and subsamples are in general agreement. The estimates show that women who have been vaccinated are actually more likely to have a Pap test in the short-run, possibly due to increased awareness of its benefits. |
| 主题 | Health, Education, and Welfare
; Health
|
| URL | https://www.nber.org/papers/w22523
|
| 来源智库 | National Bureau of Economic Research (United States)
|
| 引用统计 |
|
| 资源类型 | 智库出版物
|
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/580197
|
推荐引用方式
GB/T 7714 |
Ali Moghtaderi,Avi Dor. Immunization and Moral Hazard: The HPV Vaccine and Uptake of Cancer Screening. 2016.
|
|
文件名：
|
w22523.pdf
|
|
格式：
|
Adobe PDF
|
此文件暂不支持浏览
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
